Your browser doesn't support javascript.
loading
Yellow fever vaccine 17D administered to healthy women aged between 40 and 54 years halves breast cancer risk: an observational study.
Mastrangelo, Giuseppe; Pavanello, Sofia; Fadda, Emanuela; Buja, Alessandra; Fedeli, Ugo.
Affiliation
  • Mastrangelo G; Departments of Cardiac, Thoracic and Vascular Sciences.
  • Pavanello S; Departments of Cardiac, Thoracic and Vascular Sciences.
  • Fadda E; Departments of Cardiac, Thoracic and Vascular Sciences.
  • Buja A; Molecular Medicine, University of Padova.
  • Fedeli U; Regional Epidemiology Service, Veneto Region, Padova, Italy.
Eur J Cancer Prev ; 27(4): 303-309, 2018 07.
Article in En | MEDLINE | ID: mdl-27870643
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Yellow Fever Vaccine / Antigens, Viral Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Yellow Fever Vaccine / Antigens, Viral Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Female / Humans / Middle aged Country/Region as subject: Europa Language: En Year: 2018 Type: Article